NCT03782545已完成不适用
Multi-Center Pilot Study of Cutera truSculpt Device
Cutera Inc.5 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2018年5月11日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 34
- 试验地点
- 5
- 主要终点
- GAIS at 12 Weeks Post Final Treatment
研究概览
简要总结
Exploratory study to evaluate the safety, efficacy and ergonomics of Cutera truSculpt device.
详细描述
This study will evaluate the safety, efficacy and ergonomics of Cutera truSculpt device.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
盲法说明
This is an open label study.
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Subject must be able to read, understand and sign the Informed Consent Form.
- •Female or Male, 18 to 65 years of age (inclusive).
- •Subject has visible fat bulges in the area to be treated.
- •Non-smoking for at least 6 months and willing to refrain from smoking for the duration of the study.
- •Subject must agree to not undergo any other procedure(s) in the treatment region during the study period.
- •Subject must adhere to the follow-up schedule and study instructions.
- •Subject must adhere to the same diet and/or exercise routine throughout the study, and agree to maintain the same weight throughout the study.
- •Willing to have photographs taken of the treatment area and agree to use of photographs for presentation, (educational and/or marketing), publications, and any additional marketing purposes.
- •For female subjects: not pregnant or lactating and is either post-menopausal, surgically sterilized, or using a medically acceptable form of birth control prior to enrollment and during the entire course of the study.
排除标准
- •Participation in a clinical trial of another device or drug within 1 month of study participation, or during the study period.
- •Any type of prior cosmetic treatment to the target area within 6 months of study participation.
- •Any prior invasive cosmetic surgery to the target area, such as liposuction.
- •Has a pacemaker, internal defibrillator, implantable cardioverter-defibrillator, nerve stimulator implant, cochlear implant or any other electronically, magnetically or mechanically activated implant.
- •Has metal implant(s) within the body, such as artificial heart valves.
- •Significant uncontrolled concurrent illness that in the opinion of the Investigator would make the subject unsuitable for inclusion.
- •History of any disease or condition that could impair wound healing.
- •History of keloid formation, hypertrophic scarring or abnormal/delayed wound healing.
- •Skin abnormality in the treatment area that in the opinion of the Investigator would make the subject unsuitable for inclusion.
- •Currently undergoing systemic chemotherapy or radiation treatment for cancer, or history of treatment in the target area within 3 months of study participation.
- •Allergy or sensitivity to Tegaderm.
- •As per the Investigator's discretion, any physical or mental condition which might make it unsafe for the subject to participate in this study or a condition that would compromise the subject's ability to comply with the study requirements.
结局指标
主要结局
GAIS at 12 Weeks Post Final Treatment
时间窗: 12 weeks post final treatment
Global Aesthetic Improvement Scale will be assessed at 12 weeks post final treatment by the investigator by comparing against Baseline photos Higher scores indicate better outcomes 0= No change 1. Mild Improvement 2. Moderate improvement 3. Significant Improvement
次要结局
未报告次要终点
研究者
研究点 (5)
Loading locations...
相似试验
已完成
不适用
Multi-Center Pilot Study of truSculpt DeviceBulgingBody FatNCT03433430Cutera Inc.9
已完成
不适用
Pivotal Study of the Cutera truSculpt Radiofrequency Device for Wrinkle ReductionWrinkle ReductionNCT03285581Cutera Inc.39
已完成
不适用
Multi-Wavelength Laser Tattoo Removal Pivotal StudyTattoo RemovalNCT02935660Cutera Inc.27
已完成
不适用
The Trusculpt (Radio Frequency) Device For Thigh Circumference ReductionBody FatNCT01665118Cutera Inc.44
已完成
不适用
Pivotal Study of the truSculpt Radiofrequency Device for Circumferential ReductionAbdominal FatNCT02873104Cutera Inc.70